Skip to main content

Experimental Methods to Study the Role of the Peripheral Cannabinoid Receptor in Immune Function

  • Protocol
Marijuana and Cannabinoid Research

Part of the book series: Methods In Molecular Medicine™ ((MIMM,volume 123))

  • 906 Accesses

Summary

Marijuana components, such as Δ-9-tetrahydrocannabinol, and endogenous cannabinoids, such as anandamide and 2-arachydonoylglycerol, alter diverse immune functions. Two cannabinoid receptors have been discovered to date, the central cannabinoid receptor (CB1R) and the peripheral cannabinoid receptor (CB2R). The CB1R is expressed predominantly in the central nervous system. The CB2R is expressed mainly in cells of the immune system, suggesting that the CB2R is involved in immunoregulatory events. Cannabinoids have been shown to modulate diverse immune functions including cytokine production, lymphocyte proliferation, and humoral and cell-mediated immune responses. In addition, cannabinoids have been shown to induce different signal transduction pathways. However, the role of cannabinoids and their receptors in the immune system remains unclear. The objective of the experimental methods described herein is to investigate the role of CB2R activation in specific splenocyte and macrophage functions using a mouse lacking the CB2R. Interestingly, our findings, thus far suggest that basal CB2R activation modulates lymphocyte proliferation and cytokine secretion and macrophage phagocytic activity. Therefore, data obtained using the methodology described in this chapter will help us elucidate the role of cannabinoids and the CB2R in the immune system.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Berdyshev, E. V., et al. (1997) Influence of fatty acid ethanolamides and delta-9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. Eur. J. Pharmacol, 330, 231–240.

    Article  CAS  PubMed  Google Scholar 

  2. Klein, T. W., Friedman, H., and Specter, S. (1998) Marijuana, immunity and infection. J. Neuroimmunol. 83, 102–115.

    Article  CAS  PubMed  Google Scholar 

  3. Klein, T. W., Newton, C., and. Friedman, H. (1998) Cannabinoid receptors and immunity. Immunol. Today 19(8), 373–381.

    Article  CAS  PubMed  Google Scholar 

  4. Srivastava, M. D., Srivastava, B. I. S., and Brouhard, B. (1998) Delta-9-tetrahydrocannabinol and cannabindiol alter cytokine production by human immune cells. Immunopharmacology. 40, 179–185.

    Article  CAS  PubMed  Google Scholar 

  5. Berdyshev, E. V.(2000) Cannabinoid receptors and the regulation of immune response. Chem. Phys. Lipids 108, 169–190.

    Article  CAS  PubMed  Google Scholar 

  6. Gonsiorek, W., et al.(2000) Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Mol. Pharmacol. 57, 1045–1050.

    CAS  PubMed  Google Scholar 

  7. Gardner, B., et al. (2002) Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-b. Biochem. Biophys. Res. Commun. 290, 91–96.

    Article  CAS  PubMed  Google Scholar 

  8. Parolaro, D., et al. (2002) Endocannabinoids in the immune system and cancer. Prostaglandins, Leukotrienes Essential Fatty Acids 66(2&3), 319–332.

    Article  CAS  Google Scholar 

  9. Yuan, M., et al. (2002) Delta-9-tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J Neuroimmunol,. 133(1–2), 124–131.

    Article  CAS  PubMed  Google Scholar 

  10. Ihenetu, K., et al. (2003) Pharmacological characterisation of cannabinoid receptors inhibitng interleukin 2 release from human peripheral blood mononuclear cells. Eur. J. Pharmacol. 464, 207–215.

    Article  CAS  PubMed  Google Scholar 

  11. Klein, T., et al. (2004) Cannabinoid receptors and T helper cells. J. Neuroimmunol., 147,. 91–94.

    Article  CAS  PubMed  Google Scholar 

  12. Lopez-Rodriguez, M L., et al. (2005) Involvement of cannabinoids in cellular proliferation. Mini Rev. Med. Chem. 5(1), 97–106.

    CAS  PubMed  Google Scholar 

  13. Rodriguez de Fonseca, F., et al.(2005) The endocannabinoid system: physiology and pharmacology. Alcohol, 40(1), 2–14.

    Google Scholar 

  14. Matsuda, L., et al. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346, 561–564.

    Article  CAS  PubMed  Google Scholar 

  15. Munro, S., Thomas, K. L., and Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365 61–65.

    Article  CAS  PubMed  Google Scholar 

  16. Felder, C. C. and. Glass, M. (1998) Cannabinoid receptors and their endogenous agonists. Annu. Rev. Pharmacol. Toxicol,. 38, 179–200.

    Article  CAS  PubMed  Google Scholar 

  17. Herkenham, M., Lynn A. B., Johnson, M. R., Melvin, L. S., de Costa, B. R., Rice, K. C. (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci.. 11(2), 563–583.

    CAS  PubMed  Google Scholar 

  18. Glass, M., Dragunow, M. and. Faull, R. L. M. (1997) Cannabinoid receptors in the human brain—a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77(2), 299–218.

    Article  CAS  PubMed  Google Scholar 

  19. Buckley, N. E., Hansson, S., Harta, G., Mezey, E. (1998) Expression of the CB1 and CB2 receptor mRNAs during embryonic development in the rat. Neuroscience 82(4), 1131–1149.

    Article  CAS  PubMed  Google Scholar 

  20. Bouaboula, M., Rinaldi, M., Carayon, P., et al. (1993) Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214, 173–180.

    Article  CAS  PubMed  Google Scholar 

  21. Daaka, Y., Klein, T. W., and Friedman, H. (1995) Expression of cannabinoid receptor mRNA in murine and human leukocytes. Adv. Exp. Med. Biol,. 373,. 91–96.

    CAS  PubMed  Google Scholar 

  22. Galiegue, S., et al. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232,. 54–61.

    Article  CAS  PubMed  Google Scholar 

  23. Schatz, A. R., Lee, M., Condie, R. B., Pulaski, J. T., Kaminski, N. E. (1997) Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol. Appl. Pharmacol. 142, 278–287.

    Article  CAS  PubMed  Google Scholar 

  24. Kaminski, N. E., Abood, M. E., Kessler, F. K., Martin, B. R., Schatz, A. R. (1992) Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol. Pharmacol. 42, 736–742.

    CAS  PubMed  Google Scholar 

  25. McAllister, S. D. and Glass, M. (2002) CB1 and CB2 receptor-mediated signalling: a focus on endocannabinoids. Prostaglandins, Leukotrienes Essential Fatty Acids, 66(2&3), 161–171.

    Article  CAS  Google Scholar 

  26. Howlett, A. C., Breivogel, C. S., Childers, S. R., Deadwyler, S. A., Hampson, R. E., Porrino, L. J. (2004) Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47,. 345–358.

    Article  CAS  PubMed  Google Scholar 

  27. Bouaboula, M., Poinot-Chazel, C., Marchand, J. et al. (1996) Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur J. Biochem.. 237, 704.

    Article  CAS  PubMed  Google Scholar 

  28. Ellert-Miklaszewska, A., Kaminska, B., and. Konarska, L. (2005) Cannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein. Cell Signal 17(1), 25–37.

    Article  CAS  PubMed  Google Scholar 

  29. Karanian, D. A., Brown, Q. B., Makriyanis, A., Bahr, B. A. (2005) Blocking cannabinoid activation of FAK and ERK1/2 compromises synaptic integrity in hippocampus. Eur. J. Pharmacol,. 508(1–3), 47–56.

    Article  CAS  PubMed  Google Scholar 

  30. Powles, T., te Poele, R., Shamash, J., et al. (2005) Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway. Blood 105(3), 1214–1221.

    Article  CAS  PubMed  Google Scholar 

  31. Buckley, N. E., McCoy, K. L., Mezey, E., et al. (2000) Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor. Eur. J. Pharmacol. 396, 141–149.

    Article  CAS  PubMed  Google Scholar 

  32. Chuchawankul, S., Shima, M., Buckley, N. E., Hartmann, C. B., McCoy, K. L. (2004) Role of cannabinoid receptors in inhibiting macrophage costimulatory activity. Int. Immunopharmacol. 4(2), 265–278.

    Article  CAS  PubMed  Google Scholar 

  33. Rinaldi-Carmona, M., Barth F., Millan, J., et al. (1998) SR 144528, the first and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther 284(2), 644–650.

    CAS  PubMed  Google Scholar 

  34. Carayon, P., Marchand, J., Dussossoy, D., et al. (1998) Modulation and functional involvemnet of CB2 peripheral cannabinoid receptors during B-cell differentiation. Blood 92(10), 3605–3615.

    CAS  PubMed  Google Scholar 

  35. Bouaboula, M., Desnoyer, N., Carayon, P., Combes, T., Casellas, P. (1999) Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation. Mol. Pharmacol. 55, 473–480.

    CAS  PubMed  Google Scholar 

  36. Bouaboula, M.,. Dussossoy, D., and Casellas, P. (1999) Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528. implications for receptor biological responses. J. Biol. Chem. 274(29), 20397–20405.

    Article  CAS  PubMed  Google Scholar 

  37. Portier, M., Rinaldi-Carmona, M., Pecceu, F., et al. (1999) SR144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist. J. Pharmacol. Exp. Ther. 288(2), 582–589.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc.

About this protocol

Cite this protocol

Buckley, N.E., Burbridge, D., Buranapramest, M., Ferguson, T., Paau, R.Y. (2006). Experimental Methods to Study the Role of the Peripheral Cannabinoid Receptor in Immune Function. In: Onaivi, E.S. (eds) Marijuana and Cannabinoid Research. Methods In Molecular Medicine™, vol 123. Humana Press. https://doi.org/10.1385/1-59259-999-0:19

Download citation

  • DOI: https://doi.org/10.1385/1-59259-999-0:19

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-350-3

  • Online ISBN: 978-1-59259-999-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics